Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp, W Wick… - Journal of clinical …, 2008 - ascopubs.org
Resistance to alkylating agents via direct DNA repair by O6-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

[PDF][PDF] Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate …

ME Hegi, L Liu, JG Herman, R Stupp… - Journal of Clinical …, 2008 - scholar.archive.org
Resistance to alkylating agents via direct DNA repair by O (6)-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Resistance to alkylating agents via direct DNA repair by O (6)-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O 6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp… - Journal of Clinical …, 2008 - researchgate.net
Resistance to alkylating agents via direct DNA repair by O6-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp, W Wick… - Journal of clinical …, 2008 - sonar.ch
English Resistance to alkylating agents via direct DNA repair by O (6)-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp, W Wick… - Journal of Clinical …, 2008 - cir.nii.ac.jp
< jats: p> Resistance to alkylating agents via direct DNA repair by O< jats: sup> 6</jats: sup>-
methylguanine methyltransferase (MGMT) remains a significant barrier to the successful …

[引用][C] Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate …

ME HEGI, L LIU, JG HERMAN… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With
Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity CNRS …

[PDF][PDF] Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate …

ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller… - J Clin Oncol, 2008 - Citeseer
Resistance to alkylating agents via direct DNA repair by O6-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT …

ME Hegi, L Liu, JG Herman, R Stupp… - Journal of Clinical …, 2008 - pure.johnshopkins.edu
Resistance to alkylating agents via direct DNA repair by O 6-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT …

ME Hegi, L Liu, JG Herman… - Journal of …, 2008 - mdanderson.elsevierpure.com
Resistance to alkylating agents via direct DNA repair by O 6-methylguanine
methyltransferase (MGMT) remains a significant barrier to the successful treatment of …